Goldman Sachs’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-754,647
Closed -$7.38M 6637
2022
Q2
$7.38M Hold
754,647
﹤0.01% 2783
2022
Q1
$7.37M Hold
754,647
﹤0.01% 2989
2021
Q4
$7.32M Hold
754,647
﹤0.01% 3055
2021
Q3
$7.32M Sell
754,647
-2,800
-0.4% -$27.2K ﹤0.01% 3015
2021
Q2
$7.38M Buy
+757,447
New +$7.42M ﹤0.01% 2992

Other funds holding AONC

Goldman Sachs's AONC Position: Q3 2022 in Review

Goldman Sachs sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2022, closing a stake of 754,647 shares — an estimated $7.38M sold.

Goldman Sachs first reported a position in AONC in Q2 2021 and held it in 5 quarters. The position peaked at $7.38M in Q2 2022. 74 funds tracked by Wall St. Rank hold AONC as of Q3 2022.

  • Goldman Sachs reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 754,647 American Oncology Network, Inc. Class A Common Stock shares in Q3 2022, an estimated $7.38M.
  • Goldman Sachs first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 5 quarters.
  • Goldman Sachs's American Oncology Network, Inc. Class A Common Stock position peaked at $7.38M in Q2 2022.
  • 74 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.